Use of Recombinant Zoster Vaccine in Immunocompromised Adults Aged ≥19 Years

Recommendations of the Advisory Committee on Immunization Practices--United States, 2022

Tara C. Anderson, DVM, PhD; Nina B. Masters, PhD; Angela Guo, MPH, MBA; Leah Shepersky, MPH; Andrew J. Leidner, PhD; Grace M. Lee, MD; Camille N. Kotton, MD; Kathleen L. Dooling, MD

Disclosures

Morbidity and Mortality Weekly Report. 2022;71(3):80-84. 

In This Article

Reporting of Vaccine Adverse Events

Adverse events following vaccination can be reported to the Vaccine Adverse Events Reporting System (VAERS). Reporting is encouraged for any clinically significant adverse event even if it is uncertain whether the vaccine caused the event. Information on how to submit a report to VAERS is available at https://vaers.hhs.gov/index.html or by telephone at 1-800-822-7967.

processing....